SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Morgan Stanley Downgrades Evelo Biosciences to Equal-Weight, Announces $8 Price Target

Morgan Stanley analyst Matthew Harrison downgrades Evelo Biosciences (NASDAQ:EVLO) from Overweight to Equal-Weight and announces $8 price target.

Benzinga · 05/21/2020 10:14

Morgan Stanley analyst Matthew Harrison downgrades Evelo Biosciences (NASDAQ:EVLO) from Overweight to Equal-Weight and announces $8 price target.